
Abbott’s Esprit BTK System gains CE mark for PAD treatment
Abbott has secured the CE mark in Europe for its Esprit BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a device intended to treat peripheral artery disease (PAD) below the knee. This system is designed to maintain arterial openness …